Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-10450232 in Postoperative Dental Pain
NCT02209181Phase 2Completed
- Sponsor
- McNeil Laboratories
- Start
- Aug 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JNJ-10450232 in odontalgia (4 arms), sponsored by McNeil Laboratories. Primary endpoint: Sum of Pain Intensity Difference 0-6 Hours. Started Aug 2014; status: completed.
02
Drugs
JNJ-10450232
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT02209181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209181.